Bone Marrow Transplant Clinical Trial - Tolero Pharmaceuticals, Inc. TPI-ALV-202

CONDITION(S): Acute Myeloid Leukemia (AML) - TRIAL: Tolero Pharmaceuticals, Inc. TPI-ALV-202 - Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy

This study will evaluate the safety and efficacy of alvocidib in patients with AML who have either relapsed from or are refractory to venetoclax in combination with azacytidine or decitabine.

Drug

Alvocidib (flavopiridol) and cytarabine (Ara-C)Drug: Alvocidib (flavopiridol)

Trial Type

Interventional

Condition

Acute Myeloid Leukemia

Keywords

Acute Myeloid Leukemia (AML)